Literature for peptidase M09.002: collagenase G/A (Clostridium histolyticum)

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Therapeutic. To remove the filter click here. See explanation.)

    2016
  1. Duarte,A.S., Correia,A. and Esteves,A.C.
    Bacterial collagenases - a review
    Crit Rev Microbiol42, 106-126. PubMed  Europe PubMed DOI  U
  2. Verstreken,F., Degreef,I., Decramer,A., Libberecht,K., Vanhove,W., Datco,A., Vanhaecke,J., Clermont,D. and Duerinckx,J.
    Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease: an observational study in Belgium
    Acta Orthop Belg82, 405-411.  U
  3. 2015
  4. McCallon,S.K. and Frilot,C.
    A retrospective study of the effects of clostridial collagenase ointment and negative pressure wound therapy for the treatment of chronic pressure ulcers
    Wounds27, 44-53. PubMed  Europe PubMed  U
  5. Motley,T.A., Gilligan,A.M., Lange,D.L., Waycaster,C.R. and Dickerson,J.E., Jr.
    Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
    J Foot Ankle Res8, 7-7. PubMed  Europe PubMed DOI  U
  6. Peimer,C.A., Wilbrand,S., Gerber,R.A., Chapman,D. and Szczypa,P.P.
    Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture
    J Hand Surg Eur Vol40, 141-149. PubMed  Europe PubMed DOI  U
  7. Verheyden,J.R.
    Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique
    J Hand Surg Eur Vol40, 133-140. PubMed  Europe PubMed DOI  U
  8. Warwick,D., Arner,M., Pajardi,G., Reichert,B., Szabo,Z., Masmejean,E.H., Fores,J., Chapman,D.S., Gerber,R.A., Huard,F., Seghouani,A. and Szczypa,P.P.
    Collagenase Clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
    J Hand Surg Eur Vol40, 124-132. PubMed  Europe PubMed DOI  U
  9. Yang,K.K. and Bennett,N.
    The history of collagenase Clostridium histolyticum
    Sex Med Rev3, 289-297. PubMed  Europe PubMed DOI  U
  10. Zhang,D., Zhang,Y., Wang,Z., Zhang,X. and Sheng,M.
    Target radiofrequency combined with collagenase chemonucleolysis in the treatment of lumbar intervertebral disc herniation
    Int J Clin Exp Med8, 526-532. PubMed  Europe PubMed  U
  11. 2014
  12. Alberton,F., Corain,M., Garofano,A., Pangallo,L., Valore,A., Zanella,V. and Adani,R.
    Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases
    Musculoskelet Surg98, 225-232. PubMed  Europe PubMed DOI  U
  13. 2013
  14. Gelbard,M., Goldstein,I., Hellstrom,W.J., McMahon,C.G., Smith,T., Tursi,J., Jones,N., Kaufman,G.J. and Carson,C.C., III
    Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies
    J Urol190, 199-207. PubMed  Europe PubMed DOI  U
  15. Peimer,C.A., Skodny,P. and Mackowiak,J.I.
    Collagenase clostridium histolyticum for Dupuytren contracture: Patterns of use and effectiveness in clinical practice
    J Hand Surg Am38, 2370-2376. PubMed  Europe PubMed DOI  U
  16. Witthaut,J., Jones,G., Skrepnik,N., Kushner,H., Houston,A. and Lindau,T.R.
    Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies
    J Hand Surg Am38, 2-11. PubMed  Europe PubMed DOI  U
  17. 2012
  18. Syed,F., Thomas,A.N., Singh,S., Kolluru,V., Emeigh Hart,S.G. and Bayat,A.
    In vitro study of novel collagenase (XIAFLEX(R)) on Dupuytren's disease fibroblasts displays unique drug related properties
    PLoS ONE7, e31430-e31430. PubMed  Europe PubMed DOI  U
  19. 2011

  20. Collagenase clostridium histolyticum. Short-term benefit in Dupuytren's contracture, unknown long-term risks
    Prescrire Int20, 285-287. PubMed  Europe PubMed  U
  21. Aysan,E., Bektas,H., Ersoz,F. and Behzat,K.
    Role of single-dose clostridiopeptidase A collagenase in peritoneal adhesions
    Eur Surg Res47, 130-134. PubMed  Europe PubMed DOI  U
  22. Holzer,L. and Holzer,G.
    [Collagenase clostridum histolyticum in the management of Dupuytren's contracture]
    Handchir Mikrochir Plast Chir43, 269-274. PubMed  Europe PubMed DOI  U
  23. Kaplan,F.T.
    Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture
    Drugs Today (Barc)47, 653-667. PubMed  Europe PubMed DOI  U
  24. Karagol,B.S., Okumus,N., Dursun,A., Karadag,N. and Zenciroglu,A.
    Early and successful enzymatic debridement via collagenase application to pinna in a preterm neonate
    Pediatr Dermatol28, 600-601. PubMed  Europe PubMed DOI  U
  25. Watt,A.J. and Hentz,V.R.
    Collagenase clostridium histolyticum: a novel nonoperative treatment for Dupuytren's disease
    Int J Clin Rheumatol6, 123-133. DOI  U
  26. 2010
  27. Gilpin,D., Coleman,S., Hall,S., Houston,A., Karrasch,J. and Jones,N.
    Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease
    J Hand Surg Am35, 2027-2038. PubMed  Europe PubMed DOI  U
  28. Thomas,A. and Bayat,A.
    The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
    Ther Clin Risk Manag6, 557-572. PubMed  Europe PubMed DOI  U
  29. Watt,A.J., Curtin,C.M. and Hentz,V.R.
    Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up
    J Hand Surg Am35, 534-539. PubMed  Europe PubMed DOI  U